Robert Edfors

Chief Medical Officer

Kancera (Sweden)

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Edfors is the Chief Medical Officer at Kancera in Sweden. His research focuses on cardiovascular outcomes, particularly regarding myocardial infarction and the role of various interventions in improving patient health. Recent publications include studies on left ventricular assist device implantations and the efficacy of drug-eluting stents in patients with severe kidney dysfunction. He employs advanced methodologies such as proteomics to identify biomarkers relevant to chronic kidney disease.

Articles (6)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (7)

Torsten Holm Nielsen

Zealand University Hospital

DENMARK

View details

Tomas Jernberg

Karolinska Institutet

SWEDEN

View details

Frieder Braunschweig

Director, professor

Sahlgrenska universitetssjukhuset

SWEDEN

View details

Agneta Månsson Broberg

Karolinska Institutet

SWEDEN

View details

Michael Melin

Karolinska Institutet

SWEDEN

View details

Cecilia LInde

Karolinska University Hospital

SWEDEN

View details

Emil Najjar

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Edfors

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

Outcomes of left ventricular assist device implantations at Karolinska University Hospital: A retrospective study

A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer

Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries

Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries

Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction

SWEDEHEART-1-year data show no benefit of newer generation drug-eluting stents over bare-metal stents in patients with severe kidney dysfunction following percutaneous coronary intervention.

Collaborators (7)

Torsten Holm Nielsen

Tomas Jernberg

Frieder Braunschweig

Agneta Månsson Broberg

Michael Melin

Cecilia LInde

Emil Najjar

Make your next move.